Akoya Biosciences, Inc. (AKYA)
USD 1.63
(5.84%)
USD 1.63
(5.84%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 126.59 Million USD | 7.79% |
| 2022 | 117.45 Million USD | 68.86% |
| 2021 | 69.55 Million USD | 17.71% |
| 2020 | 59.08 Million USD | -50.58% |
| 2019 | 119.57 Million USD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q1 | 122.02 Million USD | -3.61% |
| 2024 Q2 | 121.49 Million USD | -0.44% |
| 2023 Q1 | 112.17 Million USD | -4.49% |
| 2023 FY | 126.59 Million USD | 7.79% |
| 2023 Q3 | 115.27 Million USD | -1.46% |
| 2023 Q2 | 116.97 Million USD | 4.28% |
| 2023 Q4 | 126.59 Million USD | 9.83% |
| 2022 Q2 | 93.41 Million USD | 15.93% |
| 2022 Q1 | 80.57 Million USD | 15.84% |
| 2022 Q4 | 117.45 Million USD | 15.86% |
| 2022 FY | 117.45 Million USD | 68.86% |
| 2022 Q3 | 101.36 Million USD | 8.52% |
| 2021 Q4 | 69.55 Million USD | 19.88% |
| 2021 Q2 | 58.52 Million USD | -56.48% |
| 2021 Q1 | 134.48 Million USD | 127.59% |
| 2021 FY | 69.55 Million USD | 17.71% |
| 2021 Q3 | 58.01 Million USD | -0.86% |
| 2020 Q4 | 59.08 Million USD | 0.0% |
| 2020 FY | 59.08 Million USD | -50.58% |
| 2020 Q1 | - USD | 0.0% |
| 2019 FY | 119.57 Million USD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| AngioDynamics, Inc. | 112.08 Million USD | -12.949% |
| AtriCure, Inc. | 147.76 Million USD | 14.324% |
| Avinger, Inc. | 19.97 Million USD | -533.882% |
| Azenta, Inc. | 351.22 Million USD | 63.955% |
| BioLife Solutions, Inc. | 75.05 Million USD | -68.684% |
| The Cooper Companies, Inc. | 4.1 Billion USD | 96.918% |
| Daxor Corporation | 858.75 Thousand USD | -14642.104% |
| Ekso Bionics Holdings, Inc. | 16.31 Million USD | -676.11% |
| Femasys Inc. | 9.4 Million USD | -1246.334% |
| GlucoTrack, Inc. | 1.7 Million USD | -7312.119% |
| Harvard Bioscience, Inc. | 64.29 Million USD | -96.913% |
| Hologic, Inc. | 4.02 Billion USD | 96.855% |
| ICU Medical, Inc. | 2.25 Billion USD | 94.386% |
| Intuitive Surgical, Inc. | 2.04 Billion USD | 93.807% |
| KORU Medical Systems, Inc. | 8.1 Million USD | -1461.562% |
| LeMaitre Vascular, Inc. | 48.87 Million USD | -159.01% |
| Innovative Eyewear, Inc. | 659.93 Thousand USD | -19083.527% |
| Innovative Eyewear, Inc. | 659.93 Thousand USD | -19083.527% |
| Masimo Corporation | 1.67 Billion USD | 92.45% |
| Microbot Medical Inc. | 3.82 Million USD | -3208.913% |
| Meihua International Medical Technologies Co., Ltd. | 25.07 Million USD | -404.832% |
| Merit Medical Systems, Inc. | 1.12 Billion USD | 88.729% |
| Nephros, Inc. | 3.5 Million USD | -3514.017% |
| NovoCure Limited | 783.63 Million USD | 83.845% |
| NEXGEL, Inc. | 4.78 Million USD | -2543.537% |
| NEXGEL, Inc. | 4.78 Million USD | -2543.537% |
| Singular Genomics Systems, Inc. | 86.46 Million USD | -46.423% |
| OraSure Technologies, Inc. | 52.17 Million USD | -142.648% |
| Pro-Dex, Inc. | 23.34 Million USD | -442.342% |
| Pulse Biosciences, Inc. | 16.44 Million USD | -669.88% |
| Predictive Oncology Inc. | 6.14 Million USD | -1960.038% |
| Precision Optics Corporation, Inc. | 6.84 Million USD | -1749.568% |
| QuidelOrtho Corporation | 3.55 Billion USD | 96.441% |
| Repligen Corporation | 853.2 Million USD | 85.162% |
| Sanara MedTech Inc. | 29.28 Million USD | -332.327% |
| STAAR Surgical Company | 102.73 Million USD | -23.225% |
| Sharps Technology, Inc. | 3.85 Million USD | -3184.036% |
| Utah Medical Products, Inc. | 7.14 Million USD | -1671.854% |
| DENTSPLY SIRONA Inc. | 4.07 Billion USD | 96.894% |
| Jin Medical International Ltd. | 8.92 Million USD | -1318.58% |